ARCHIVES

FDA to refer false statements by regulated companies to SEC.

This article is from The Cancer Letter archive.

Vol. 30 No. 09 | February 27, 2004

Download PDF Visit The Full Archive

Related Articles

NCI Programs: Institute Funds 24 DNA Microarray Centers

September 24, 1999

Program Announcements For Studies On Blue Collar Workers, Children Released By DRCCA

November 5, 1982

National TV Attack On Cancer Program Gets Response From Schmidt; Some NCAB Members Side With Kornberg

June 28, 1974

Leter: Payers Must Determine Appropriate Therapies

July 19, 1996

Letter: Headline Criticized On Letter About Consortium

June 21, 1996

In Brief: Einstein Center Wins BMS Research Grant; M.D. Anderson Honors Frederick Becker

March 26, 1999